The Venture Codex Logo

The Venture Codex

Advent Life Sciences

27 Fitzroy Square, London, Greater London, W1T 6ES, United Kingdom

Overview

Venture team investing in life sciences businesses and technologies.

Founded

2009

Deals · 12mo

1

Links

WebsiteLinkedIn

Stage focus

Series A
Series B

Geographic focus

United Kingdom
United States

Sector focus

Finance
Financial Services
Venture Capital

Investment portfolio

56rounds
NAMEDATESIZE
Beacon Therapeutics
Jan 2026Participated
$75 MSeries C
Cyted
Sep 2025Led
$44 MSeries B
Glycomine
Apr 2025Led
$115 MSeries C
Relief Cardiovascular
Jan 2025Led
$12 MSeries A
Epitopea
Oct 2024Participated
$31 MSeries A
F2G
Sep 2024Participated
$100 MOther Equity
Moximed
Aug 2024Participated
$61 MSeries D
Artax Biopharma
Aug 2024Participated
$8 MOther Equity
Beacon Therapeutics
Jul 2024Participated
$170 MSeries B
Curve Therapeutics
Feb 2024Participated
$51 MSeries A
Argá Medtech
Feb 2024Led
$59 MSeries B
PIC Therapeutics
Oct 2022Participated
$35 MSeries A
Beacon Therapeutics
Jan 2026Participated
$75 MSeries C
Cyted
Sep 2025Led
$44 MSeries B
Glycomine
Apr 2025Led
$115 MSeries C
Relief Cardiovascular
Jan 2025Led
$12 MSeries A
Epitopea
Oct 2024Participated
$31 MSeries A
F2G
Sep 2024Participated
$100 MOther Equity
Moximed
Aug 2024Participated
$61 MSeries D
Artax Biopharma
Aug 2024Participated
$8 MOther Equity
Beacon Therapeutics
Jul 2024Participated
$170 MSeries B
Curve Therapeutics
Feb 2024Participated
$51 MSeries A
Argá Medtech
Feb 2024Led
$59 MSeries B
PIC Therapeutics
Oct 2022Participated
$35 MSeries A
56
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Advent Life Sciences: 56 funding rounds are recorded in the selected participation categories.All available history.
Advent Life Sciences: 56 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed21
Series A49
Series B410
Series C+38
Other Equity312

Monthly Deal Activity

Advent Life Sciences: 56 deals are recorded across 178 months.All available history.
Advent Life Sciences: 56 deals are recorded across 178 months. All available history
MonthDeals
Jan '121
Feb '120
Mar '120
Apr '120
May '120
Jun '120
Jul '120
Aug '120
Sep '120
Oct '120
Nov '121
Dec '120
Jan '130
Feb '130
Mar '130
Apr '130
May '130
Jun '130
Jul '130
Aug '132
Sep '130
Oct '130
Nov '130
Dec '130
Jan '140
Feb '141
Mar '140
Apr '140
May '140
Jun '140
Jul '140
Aug '140
Sep '140
Oct '141
Nov '140
Dec '140
Jan '150
Feb '150
Mar '151
Apr '150
May '150
Jun '150
Jul '150
Aug '150
Sep '151
Oct '150
Nov '150
Dec '151
Jan '160
Feb '161
Mar '162
Apr '160
May '160
Jun '161
Jul '160
Aug '160
Sep '160
Oct '160
Nov '160
Dec '160
Jan '171
Feb '172
Mar '171
Apr '171
May '172
Jun '170
Jul '170
Aug '170
Sep '170
Oct '170
Nov '170
Dec '171
Jan '180
Feb '180
Mar '180
Apr '181
May '180
Jun '180
Jul '180
Aug '181
Sep '180
Oct '180
Nov '180
Dec '180
Jan '190
Feb '190
Mar '190
Apr '192
May '190
Jun '190
Jul '190
Aug '190
Sep '190
Oct '190
Nov '190
Dec '190
Jan '200
Feb '200
Mar '200
Apr '203
May '200
Jun '200
Jul '200
Aug '201
Sep '200
Oct '201
Nov '200
Dec '200
Jan '210
Feb '211
Mar '212
Apr '210
May '210
Jun '210
Jul '211
Aug '210
Sep '210
Oct '210
Nov '210
Dec '211
Jan '220
Feb '221
Mar '220
Apr '221
May '221
Jun '222
Jul '221
Aug '222
Sep '221
Oct '221
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '242
Mar '240
Apr '240
May '240
Jun '240
Jul '241
Aug '242
Sep '241
Oct '241
Nov '240
Dec '240
Jan '251
Feb '250
Mar '250
Apr '251
May '250
Jun '250
Jul '250
Aug '250
Sep '251
Oct '250
Nov '250
Dec '250
Jan '261
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Advent Life Sciences: Health & Life Sciences is the largest displayed sector by deal count (55 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Advent Life Sciences: Health & Life Sciences is the largest displayed sector by deal count (55 deals). All available history
SectorDeals
Health & Life Sciences55
Manufacturing7
AI & Machine Learning2
Data, Analytics & IT2
Networks, Cloud & Communication1
Hardware & Robotics1
AR/VR1
Professional Services1
Social & Community Platforms1

Deal Size Distribution

Advent Life Sciences: 56 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Advent Life Sciences: 56 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M1
$5M-$10M6
$10M-$25M11
$25M-$50M16
$50M-$100M18
$100M-$250M4
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Advent Life Sciences: United States has the largest recorded deal count among the displayed regions (31 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Advent Life Sciences: United States has the largest recorded deal count among the displayed regions (31 deals). All available history
RegionDeals
United States31
Europe25
Advent Life Sciences: 20 co-investors are shown, with Columbus Venture Partners sharing 8 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Advent Life Sciences: 20 co-investors are shown, with Columbus Venture Partners sharing 8 recorded deals. All available history
Co-investorShared deals
Columbus Venture Partners8
Forbion8
OrbiMed8
Gilde Healthcare7
Novo Holdings7
Arix Bioscience5
Canaan Partners5
Chiesi Ventures5
Medicxi4
New Enterprise Associates4
Novartis4
Osage University Partners4
Ysios Capital4
Alexandria Venture Investments3
Brace Pharma Capital3
Celgene3
CTI Life Sciences Fund3
Eli Lilly and Company3
Fountain Healthcare Partners3
Future Fund3

Investment Strategy

Advent Life Sciences: Led accounts for 29% and participating for 71% of round participation.All available history.
Advent Life Sciences: Led accounts for 29% and participating for 71% of round participation. All available history
CategoryDeals (count)Share (%)
Led1629%
Participating4071%
Advent Life Sciences: Single-lead accounts for 50% and co-led for 50% of lead dynamics.All available history.
Advent Life Sciences: Single-lead accounts for 50% and co-led for 50% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead850%
Co-led850%

Team

Alain Huriez

Partner

Andrew J Wood

Venture Partner

Dale Pfost

General Partner

Don Drakeman

Venture Partner

Naseem Amin

Venture Partner

Praveen Kokate

Owner

Satish Jindal

General Partner

Simon Kerry

Operating Partner